Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?
Events surrounding the coronavirus contagion, characterized as a “black swan” event, which started in China, remain very fluid and are changing daily. No one really knows what ...
One Important Lesson From Biogen’s Surprise Announcement On Hopes For An Alzheimer’s Drug
This white paper lays out the reasons for these changes and action steps executives must make to shift from the current volume-based to value/outcomes-based commercial model design ...
Importation Of Drugs Is Back Again On The Pharma Public Policy Table – A Short Commentary
This commentary white paper provides reasons why importation is still a bad idea today, but more importantly, why the reintroduction of this policy is a reflection of the broader e ...
AstraZeneca’s Bold And Potentially Risky New Cancer Drug R&D Portfolio Strategy
This paper explores the challenges and opportunities this new strategy can have for AstraZeneca while providing other pharma companies that are contemplating a similar different R& ...
How Will The Next Great Recession Affect The US Pharma Industry?
The US will have another recession as certain as night follows day. The business cycle has not been outlawed nor made extinct, contrary to the overly optimistic views of macroecono ...
Perspectives On The Design And Effectiveness Of Pharma Sales Contests
This white paper covers an array of topics pertaining to the development, execution, and outcomes from sales contests to provide sales operations leaders practical guidance on key ...
Do Pharma Mergers And Acquisitions Improve R&D Productivity And Increase Shareholder Value?
Mergers & acquisitions (M&As) have long been used as a critical strategic instrument by pharmaceutical company executives to spur R&D innovation, sustain financial grow ...
Future Of Pharma: Evolving Commercial Models – Part 2
Learn what several senior pharma commercial operations leaders think of the potential implications of industry challenges on business operations, sales and marketing objectives and ...
Politics ‘Trumps’ Rational Policy Rule Change On Ending Rebates To PBMs For The Medicare Program
This paper explores the reason behind this about-face, potential policy alternatives President Trump may pursue to reduce drug prices and their adverse consequences, and what shoul ...
As the coronavirus (COVID-19) global pandemic unfolds, we would like to share our plans to conduct our business seamlessly while giving utmost priority to the health and well-being of our employees and our ecosystem of customers, vendors, and partners.
Our hearts go out to anyone directly or indirectly impacted by this pandemic. We are inspired by the selfless service of healthcare workers, first responders, and other professionals who continue to serve the people in need.
Our two main priorities at Axtria include:
We pride ourselves on being a highly customer-centric company. Rest assured, we will continue to help achieve all business goals by ensuring that our team is fully equipped to stand in support. Our integrated cloud platforms enable global commercial organizations to work seamlessly and automate manual processes. They are built from the ground up to support teams that need to work remotely.
To ensure health and safety, we have asked our employees globally to follow the guidelines of the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and maintain social distancing, work from home, and swap in-person meetings with phone and video calls. Assuredly, our employees are well-versed in remote work, given our technology infrastructure, ongoing training, and existing processes. We have also rescheduled all in-person events in the coming weeks to digital platforms. Doing so allows us to suspend all unnecessary business travel and large gatherings.
Lastly, we will continue monitoring the COVID-19 data and will make operational adjustments as needed. As a data analytics company, we are committed to making data-driven decisions in every aspect of the business. We shall continue doing so using the most reliable data - from the WHO, the CDC, data-based case tracking via Johns Hopkins University (JHU), as well as through national and local administrations.
As always, Axtria will continue to provide our unwavering support. In dealing with the present circumstances, we will continue employing every effort to deliver uninterrupted services.
Further, you can bank on us to alert you of any protocol changes while encouraging you to approach us with your feedback and queries – not just as business partners, but as valued friends.
On behalf of all Axtrians, I wish you and your families safety and good health during these trying times.
We are isolated but united!
All the best,